NAT Diagnostics Overview

  • Founded
  • 2014
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 2
Employees
  • Latest Deal Type
  • M&A

NAT Diagnostics General Information

Description

Developer of a molecular diagnostic platform designed to provide true Point-of-Care testing for infectious disease. The company's platform uses a technology that is based on a novel isothermal nucleic acid amplification and detection method that requires only ten minutes, enabling physicians' offices, clinics and pharmacies to offer Point-of-Care testing results which are highly accurate and costs low.

Contact Information

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Primary Office
  • 11585 Sorrento Valley Road
  • Suite 107
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NAT Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 15-May-2020 00.000 Completed Generating Revenue
3. Angel (individual) 16-Nov-2017 00.00 00.000 Completed Startup
2. Angel (individual) 11-Sep-2015 $2.91M $2.91M Completed Startup
1. Accelerator/Incubator 20-Apr-2015 Completed Startup
To view NAT Diagnostics’s complete valuation and funding history, request access »

NAT Diagnostics Executive Team (1)

Name Title Board Seat Contact Info
Andrew Miller Ph.D Founder, Chief Executive Officer, Chief Financial Officer & Board Member
To view NAT Diagnostics’s complete executive team members history, request access »

NAT Diagnostics Board Members (4)

Name Representing Role Since
Allan Fan NAT Diagnostics Board Member 000 0000
Andrew Miller Ph.D NAT Diagnostics Founder, Chief Executive Officer, Chief Financial Officer & Board Member 000 0000
David Galas NAT Diagnostics Board Member 000 0000
Thomas Wu NAT Diagnostics Board Member 000 0000
To view NAT Diagnostics’s complete board members history, request access »

NAT Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NAT Diagnostics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JLABS Accelerator/Incubator 000 0000 000000 0
To view NAT Diagnostics’s complete investors history, request access »